SPS-1
Report
- Report Number
- 6202031
- Event Type
- Malfunction
- Date Received
- December 23, 2016
- Date of Event
- December 16, 2016
- Report Date
- December 22, 2016
- Manufacturer
- ORGAN RECOVERY SYSTEMS, INC
- Product Code
- KDN
- Product Problem
- Yes
- Report Source
- User Facility report
- Reporter Location
- WI, US
- Reporter Occupation
- OTHER
Narratives
APPROXIMATELY 6 DAYS AGO, OUR OPO (ORGAN PROCUREMENT ORGANIZATION) RECEIVED COMMUNICATION FROM (B)(6) THAT THERE WAS CONTAMINATED ORGAN PRESERVATION FLUID USED IN TRANSPLANT CASES. OUR OPO ESCALATED INFORMATION REGARDING PATIENTS AT OUR FACILITY. IMPACTED PATIENTS WERE AS FOLLOWS: WE RECEIVED A NOTIFICATION OVER THE WEEKEND THAT THERE WAS CONTAMINATED ORGAN PRESERVATION SOLUTION DISCOVERED PER THE MESSAGE FROM THE (B)(6). WE RECEIVED THE E-MAIL FROM OUR OPO (ORGAN PROCUREMENT ORGANIZATION) INFORMING US THAT THEY CHECKED THE SOLUTION BATCH NUMBERS AND DISCOVERED THAT WE USED THIS SOLUTION ON SEVERAL OF OUR PATIENTS. A TOTAL OF SIX PATIENTS AT THIS FACILITY RECEIVED ORGAN TRANSPLANTS THAT WERE AFFECTED BY THE CONTAMINATED ORGAN PRESERVATION FLUID. THE FIRST PATIENT WAS READMITTED APPROXIMATELY TWO WEEKS AFTER TRANSPLANT FOR TREATMENT OF HYDRONEPHROSIS AND CHRONIC UTIS. THE SECOND PATIENT RECEIVED ADDITIONAL MEDICATION TO COVER THE POTENTIAL INFECTION RELATED TO THE CONTAMINATED ORGAN PRESERVATION FLUID. THE THIRD PATIENT'S MEDICATIONS DURING HOSPITALIZATION AND AT DISCHARGE WERE ADJUSTED TO COVER THE ORGANISMS REPORTED IN THE CONTAMINATED ORGAN PRESERVATION FLUID. THE FOURTH PATIENT HAS NO SIGNS OF INFECTION AND HAD NO CHANGES TO THEIR PLAN OF CARE. THE FIFTH PATIENT IS BEING SEEN BY ID (INFECTIOUS DISEASE) CONSULT TEAM AND PT ON EMPIRIC THERAPY FOR THE ORGANISMS IN THE PRESERVATION SOLUTION AND POSSIBLE HCAP (HEALTH CARE ASSOCIATED PNEUMONIA).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 852466 | SPS-1 | SYSTEM, PERFUSION, KIDNEY | KDN | ORGAN RECOVERY SYSTEMS, INC | PBR-0074-330 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |